GlassScriptPhysician profile
Sara Saavedra
NPI 1548896426
$3,873.73
in general payments reported to CMS, 2019-2025
18 companies · $724 in 2025
The $724 reported for 2025 was more than what 81% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $3,113 · 2024: $36.01 · 2025: $724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,830 · Travel and Lodging: $1,071 · Food and Beverage: $973.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,830.00 |
| Travel and Lodging | $1,070.54 |
| Food and Beverage | $973.19 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $3,113.49 | 2023 | Epclusa |
| Xeris Pharmaceuticals, INC. | $144.47 | 2025 | Recorlev, Gvoke Hypopen |
| Bayer Healthcare Pharmaceuticals INC. | $96.76 | 2025 | |
| Corcept Therapeutics | $70.87 | 2025 | Korlym |
| Radius Health, INC. | $67.49 | 2025 | Tymlos |
| Lilly USA, LLC | $64.42 | 2025 | Zepbound, Mounjaro, Jardiance |
| Mannkind Corporation | $61.42 | 2025 | |
| Abbvie INC. | $36.29 | 2025 | |
| Cequr Corporation | $34.16 | 2025 | Cequr Simplicity |
| Recordati_rare_diseases_inc. | $27.34 | 2025 | Isturisa |
| Medtronic, INC. | $26.63 | 2025 | Minimed 780g |
| Boehringer Ingelheim Pharmaceuticals, INC. | $25.43 | 2025 | Jardiance |
| Astellas Pharma US INC | $22.46 | 2024 | Veozah |
| Exact Sciences Corporation | $21.09 | 2025 | Cologuard Collection Kit |
| Ascendis Pharma Endocrinology INC | $17.62 | 2025 | Yorvipath |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $15.98 | 2025 | Evenity |
| Tandem Diabetes Care, INC. | $14.26 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Sumitomo Pharma America, INC. | $13.55 | 2024 | Myfembree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sara Saavedra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.